Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Partners LP

52.63
+0.89001.72%
Volume:25.57K
Turnover:1.34M
Market Cap:1.77B
PE:21.84
High:53.15
Open:51.74
Low:50.40
Close:51.74
Loading ...

Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone

Benzinga
·
28 Feb

HP, Dell Technologies And 3 Stocks To Watch Heading Into Friday

Benzinga
·
28 Feb

Lexaria Bioscience Advances Strategy in GLP-1 Drug Sector

TIPRANKS
·
28 Feb

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

ACCESS Newswire
·
27 Feb

GLP J-REIT Sets Interest Rate for 3 Billion Yen Loan; Executes Swap Agreement

MT Newswires Live
·
27 Feb

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

GlobeNewswire
·
26 Feb

Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage. -- Barrons.com

Dow Jones
·
25 Feb

Hims & Hers (HIMS) Sees 69% Revenue Increase Despite GLP-1 Uncertainties

TIPRANKS
·
25 Feb

Lexaria Bioscience Advances GLP-1 Study with New Ethics Approval

TIPRANKS
·
24 Feb

Lexaria receives HREC approval for DehydraTECH-tirzepatide GLP-1 study arm

TIPRANKS
·
24 Feb

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

ACCESS Newswire
·
24 Feb

Zacks Industry Outlook Highlights Targa Resources, Global Partners and CrossAmerica

Zacks
·
24 Feb

3 Solid Options Amid Refining & Marketing MLP Industry Tumult

Zacks
·
21 Feb

GLP J-REIT Enhances ESG Financing with New Loan Strategy

TIPRANKS
·
20 Feb

Eli Lilly and Company (LLY) Slid as its GLP-1 Revenue Missed Expectations

Insider Monkey
·
19 Feb

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Business Wire
·
19 Feb

Allurion Technologies to initiate Allurion Balloon with GLP-1 agonists study

TIPRANKS
·
18 Feb

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Business Wire
·
18 Feb

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

GlobeNewswire
·
18 Feb

Hims & Hers Health: Navigating Growth Potential Amidst Elevated Stock Expectations and GLP-1 Volatility

TIPRANKS
·
18 Feb